SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (6848)7/12/1999 12:23:00 PM
From: aknahow  Read Replies (2) | Respond to of 9719
 
General question related to concluded clinical trials.

If a trial has been concluded but not all the look back points have been reached by every subject in the trial, when can the decision to un-blind the data be made?

I have not interjected a specific company into this question. Mention of the company might diver attention from the question itself.



To: Rocketman who wrote (6848)7/13/1999 12:32:00 AM
From: sim1  Read Replies (1) | Respond to of 9719
 
>>Incidentally (or maybe not), CLTR has apparently been heavily shorted of late.<<

Assuming this to be true, can anyone hazard a guess as to the likely effect on the price of the stock (CLTR) near term? (Perhaps a potential buying opportunity followed by a short squeeze?)

Message 10478197


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News